MARKET

FBIOP

FBIOP

Fortress Biotech Inc
NASDAQ
6.61
+0.37
+5.93%
Closed 15:55 05/15 EDT
OPEN
6.26
PREV CLOSE
6.24
HIGH
6.70
LOW
6.26
VOLUME
10.15K
TURNOVER
0
52 WEEK HIGH
17.25
52 WEEK LOW
4.720
MARKET CAP
22.65M
P/E (TTM)
-2.4581
1D
5D
1M
3M
1Y
5Y
1D
FORTRESS BIOTECH INC - FDA ACCEPTS NDA FOR CUTX-101 WITH PDUFA DATE SEPT 30, 2025
Reuters · 20h ago
FORTRESS BIOTECH INC - SUN PHARMA TO BUY CHECKPOINT THERAPEUTICS, TRANSACTION TO TAKE PLACE ON MAY 28, 2025
Reuters · 20h ago
Checkpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Reuters · 2d ago
Weekly Report: what happened at FBIOP last week (0505-0509)?
Weekly Report · 4d ago
Weekly Report: what happened at FBIOP last week (0428-0502)?
Weekly Report · 05/05 09:56
Weekly Report: what happened at FBIOP last week (0421-0425)?
Weekly Report · 04/28 10:00
Weekly Report: what happened at FBIOP last week (0414-0418)?
Weekly Report · 04/21 10:00
Weekly Report: what happened at FBIOP last week (0407-0411)?
Weekly Report · 04/14 09:56
More
About FBIOP
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIOP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIOP stock methods without spending real money on the virtual paper trading platform.